Kaneka Expands CoQ10 Facilities at Takasago Plant.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Dec 28, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Kaneka announced on December December: see month. 22 that it has completed the planned expansion of its CoQ CoQ coenzyme Q (ubiquinone). 10 facilities in Takasago, Japan, and has begun commercial shipment of KanekaQ10 to customers after meeting the required pharmaceutical validations and safety confirmation of its production facility. The expansion brings Kaneka's annual CoQ10 production capacity in Japan from 150 metric tons to 180 metric tons, an expansion needed in order to meet steadily increasing CoQ10 demand worldwide. Meanwhile, in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Kaneka Nutrients L.P., in Pasadena, Texas, a fully owned subsidiary of Kaneka Corporation of Japan, is currently building a new CoQ10 plant with an annual production capacity of 100 metric tons. This Phase I construction, although affected by two recent hurricanes, is expected to be completed by the summer of 2006, thus enabling Kaneka to better meet the strong increase in CoQ10 consumption both in the United States market and in the Japanese and other worldwide markets. Kaneka is planning further expansion of its CoQ10 production capacity in both of its U.S. and Japanese facilities. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion